Praxis Precision Medicines Q1 Loss Narrows Amid Higher Operating Expenses
08:53 AM EDT, 05/11/2021 (MT Newswires) -- Praxis Precision Medicines (PRAX) reported a Q1 net loss of $0.71 per share, compared with a loss of $6.08 per share a year earlier.
Analysts polled by Capital IQ projected a loss of $0.74 per share.
Operating expenses were $27.4 million for the quarter ended March 31, up from $8.5 million a year ago.
As of March 31, the company had $270.8 million in cash, cash equivalents and marketable securities.
Price: 25.86, Change: -2.20, Percent Change: -7.84